Skip to main content
. 2016 Aug 31;7(40):66192–66201. doi: 10.18632/oncotarget.11751

Figure 3. In vivo immunologic response to vaccination.

Figure 3

In vivo immune responses were determined using a delayed type hypersensitivity (DTH) reaction. Patients who were vaccinated with GP2+GM-CSF had a significant increase in their DTH reaction to both the immunizing peptide post-vaccination compared to pre-vaccination. (* = P < 0.001).